End-of-day quote
Korea S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
2,11,500
KRW
|
-4.30%
|
|
+1.20%
|
+41.57%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
13,42,298
|
23,52,299
|
18,64,449
|
15,97,992
|
16,75,393
|
22,42,856
|
-
|
-
|
Enterprise Value (EV)
2 |
860
|
1,843
|
1,406
|
1,219
|
1,675
|
1,800
|
1,723
|
1,803
|
P/E ratio
|
37.5
x
|
56.2
x
|
33
x
|
29.7
x
|
18.8
x
|
22.7
x
|
17.6
x
|
14
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.56
x
|
11.1
x
|
7.61
x
|
5.67
x
|
5.24
x
|
5.85
x
|
5.05
x
|
4.5
x
|
EV / Revenue
|
4.2
x
|
8.73
x
|
5.74
x
|
4.33
x
|
5.24
x
|
4.7
x
|
3.88
x
|
3.61
x
|
EV / EBITDA
|
11.1
x
|
20.8
x
|
12.6
x
|
10.6
x
|
12.7
x
|
11.1
x
|
8.67
x
|
7.36
x
|
EV / FCF
|
13.3
x
|
32.2
x
|
22.7
x
|
25.2
x
|
-
|
26
x
|
18.8
x
|
24
x
|
FCF Yield
|
7.52%
|
3.11%
|
4.41%
|
3.96%
|
-
|
3.84%
|
5.33%
|
4.16%
|
Price to Book
|
2.37
x
|
3.15
x
|
2.41
x
|
2.03
x
|
-
|
2.73
x
|
2.39
x
|
2
x
|
Nbr of stocks (in thousands)
|
10,126
|
12,526
|
12,146
|
11,846
|
11,214
|
10,914
|
-
|
-
|
Reference price
3 |
1,32,565
|
1,87,800
|
1,53,500
|
1,34,900
|
1,49,400
|
2,05,500
|
2,05,500
|
2,05,500
|
Announcement Date
|
12/03/20
|
09/02/21
|
10/02/22
|
09/02/23
|
14/02/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
204.6
|
211
|
245.2
|
281.7
|
319.7
|
383.3
|
444.5
|
498.8
|
EBITDA
1 |
77.57
|
88.76
|
111.5
|
115.4
|
131.6
|
161.5
|
198.8
|
245
|
EBIT
1 |
68.09
|
78.21
|
97.14
|
102.5
|
117.8
|
148.7
|
185
|
227.9
|
Operating Margin
|
33.28%
|
37.06%
|
39.62%
|
36.39%
|
36.86%
|
38.78%
|
41.62%
|
45.69%
|
Earnings before Tax (EBT)
1 |
69.73
|
81.7
|
89.01
|
66.51
|
132.8
|
147.8
|
189.5
|
221.2
|
Net income
1 |
44.61
|
51.87
|
57.52
|
57.66
|
92.3
|
106.1
|
136.2
|
164.1
|
Net margin
|
21.81%
|
24.58%
|
23.46%
|
20.47%
|
28.87%
|
27.69%
|
30.65%
|
32.91%
|
EPS
2 |
3,532
|
3,344
|
4,658
|
4,545
|
7,934
|
9,068
|
11,698
|
14,633
|
Free Cash Flow
3 |
64,701
|
57,325
|
62,061
|
48,272
|
-
|
69,220
|
91,765
|
75,000
|
FCF margin
|
31,627.96%
|
27,164.44%
|
25,315.05%
|
17,137.58%
|
-
|
18,057.12%
|
20,644.5%
|
15,037.5%
|
FCF Conversion (EBITDA)
|
83,406.25%
|
64,581.67%
|
55,680.25%
|
41,840.33%
|
-
|
42,865.85%
|
46,167.85%
|
30,608.74%
|
FCF Conversion (Net income)
|
1,45,029.21%
|
1,10,517.41%
|
1,07,903.34%
|
83,717.39%
|
-
|
65,218.98%
|
67,352.37%
|
45,699.24%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/03/20
|
09/02/21
|
10/02/22
|
09/02/23
|
14/02/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
55.79
|
61.01
|
64.9
|
67.4
|
70.68
|
85.49
|
64.38
|
81.56
|
84.82
|
88.94
|
78.98
|
91.28
|
109.8
|
106.8
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
32.82
|
21.88
|
31.38
|
37.69
|
40.34
|
28.5
|
41
|
45.5
|
46.5
|
EBIT
1 |
21.35
|
19.74
|
24.99
|
22.32
|
24.77
|
31.17
|
18.5
|
27.98
|
34.55
|
36.79
|
26.75
|
34.02
|
45.9
|
43.2
|
Operating Margin
|
38.27%
|
32.35%
|
38.5%
|
33.12%
|
35.05%
|
36.46%
|
28.74%
|
34.31%
|
40.74%
|
41.36%
|
33.87%
|
37.28%
|
41.79%
|
40.46%
|
Earnings before Tax (EBT)
1 |
28.4
|
11.42
|
22.14
|
23.16
|
31.94
|
-12.58
|
24.28
|
30.87
|
53.65
|
24.01
|
29.3
|
30.2
|
38.2
|
46.1
|
Net income
1 |
20.24
|
3.717
|
14.98
|
14.78
|
25.76
|
2.143
|
16.38
|
21.11
|
39.39
|
15.42
|
22.3
|
23
|
29.2
|
35.2
|
Net margin
|
36.28%
|
6.09%
|
23.08%
|
21.93%
|
36.45%
|
2.51%
|
25.43%
|
25.88%
|
46.44%
|
17.34%
|
28.24%
|
25.2%
|
26.59%
|
32.97%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/11/21
|
10/02/22
|
11/05/22
|
10/08/22
|
10/11/22
|
09/02/23
|
10/05/23
|
09/08/23
|
13/11/23
|
14/02/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
482
|
509
|
458
|
379
|
-
|
442
|
520
|
440
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
64,701
|
57,325
|
62,061
|
48,272
|
-
|
69,220
|
91,765
|
75,000
|
ROE (net income / shareholders' equity)
|
6.25%
|
5.81%
|
7.58%
|
7%
|
-
|
13.2%
|
14.7%
|
15%
|
ROA (Net income/ Total Assets)
|
4.92%
|
4.54%
|
5.87%
|
5.33%
|
-
|
9.94%
|
11%
|
11.9%
|
Assets
1 |
906.5
|
1,143
|
979.4
|
1,082
|
-
|
1,068
|
1,242
|
1,379
|
Book Value Per Share
3 |
55,845
|
59,612
|
63,708
|
66,477
|
-
|
75,322
|
85,975
|
1,02,684
|
Cash Flow per Share
3 |
5,330
|
5,917
|
6,606
|
6,817
|
-
|
8,086
|
10,762
|
-
|
Capex
1 |
12.3
|
17
|
23.9
|
33
|
-
|
30
|
27.6
|
27
|
Capex / Sales
|
6.01%
|
8.04%
|
9.74%
|
11.7%
|
-
|
7.82%
|
6.21%
|
5.41%
|
Announcement Date
|
12/03/20
|
09/02/21
|
10/02/22
|
09/02/23
|
14/02/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
2,05,500
KRW Average target price
2,18,778
KRW Spread / Average Target +6.46% Consensus |
1st Jan change
|
Capi.
|
---|
| +41.57% | 1.67B | | -3.85% | 86.16B | | +2.76% | 40.17B | | -17.49% | 31.47B | | +54.44% | 25.24B | | -13.13% | 15.82B | | -9.12% | 11.96B | | -15.45% | 11.89B | | -42.56% | 11.61B | | +4.87% | 8.84B |
Biopharmaceuticals
|